Literature DB >> 14984468

Skeletal phenotype in patients with Shwachman-Diamond syndrome and mutations in SBDS.

O Mäkitie1, L Ellis, P R Durie, J A Morrison, E B Sochett, J M Rommens, W G Cole.   

Abstract

Pancreatic exocrine and bone marrow dysfunctions are considered to be universal features of Shwachman-Diamond syndrome (SDS) whereas the associated skeletal dysplasia is variable and not consistently observed. The genetic defect in SDS has recently been identified; causative mutations have been shown in the SBDS gene. The aims of this study were to characterize the nature, frequency, and age-related changes of radiographic skeletal abnormalities in patients with SBDS mutations and to assess genotype-phenotype correlation. Fifteen patients (mean age 9.7 years) with a clinical diagnosis of SDS and documented SBDS gene mutations were included. Review of their skeletal radiographs showed abnormalities in all patients. The skeletal changes were variable, even in patients with identical genotypes. The typical features were (1) delayed appearance of secondary ossification centers, (2) variable widening and irregularity of the metaphyses in early childhood, followed by progressive thickening and irregularity of the growth plates, and (3) generalized osteopenia. There was a tendency towards normalization of the epiphyseal maturation defect and progression of the metaphyseal changes with age. The results suggest that the characteristic skeletal changes are present in all patients with SDS and SBDS mutations, but their severity and localization varies with age. No phenotype-genotype correlation was observed.

Entities:  

Mesh:

Year:  2004        PMID: 14984468     DOI: 10.1111/j.0009-9163.2004.00198.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  36 in total

1.  BLM helicase facilitates RNA polymerase I-mediated ribosomal RNA transcription.

Authors:  Patrick M Grierson; Kate Lillard; Gregory K Behbehani; Kelly A Combs; Saumitri Bhattacharyya; Samir Acharya; Joanna Groden
Journal:  Hum Mol Genet       Date:  2011-11-21       Impact factor: 6.150

Review 2.  Neonatal manifestations of inherited bone marrow failure syndromes.

Authors:  Payal P Khincha; Sharon A Savage
Journal:  Semin Fetal Neonatal Med       Date:  2015-12-24       Impact factor: 3.926

Review 3.  Shwachman-Diamond syndrome: UK perspective.

Authors:  G W Hall; P Dale; J A Dodge
Journal:  Arch Dis Child       Date:  2006-06       Impact factor: 3.791

4.  Lentiviral-mediated RNAi inhibition of Sbds in murine hematopoietic progenitors impairs their hematopoietic potential.

Authors:  Amy S Rawls; Alyssa D Gregory; Jill R Woloszynek; Fulu Liu; Daniel C Link
Journal:  Blood       Date:  2007-07-17       Impact factor: 22.113

Review 5.  Shwachman-Bodian-Diamond syndrome: metaphyseal chondrodysplasia in children with pancreatic insufficiency and neutropenia.

Authors:  Terry L Levin; Outi Mäkitie; Walter E Berdon; Ralph S Lachman
Journal:  Pediatr Radiol       Date:  2014-11-23

6.  Loss of the mouse ortholog of the shwachman-diamond syndrome gene (Sbds) results in early embryonic lethality.

Authors:  Siyi Zhang; Mingjun Shi; Chi-Chung Hui; Johanna M Rommens
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

Review 7.  Shwachman-Diamond syndrome.

Authors:  C Dall'oca; M Bondi; M Merlini; M Cipolli; F Lavini; P Bartolozzi
Journal:  Musculoskelet Surg       Date:  2011-12-27

8.  Shwachman-Bodian Diamond syndrome is a multi-functional protein implicated in cellular stress responses.

Authors:  Heather L Ball; Bing Zhang; J Jacob Riches; Rikesh Gandhi; Jing Li; Johanna M Rommens; Jeremy S Myers
Journal:  Hum Mol Genet       Date:  2009-07-14       Impact factor: 6.150

Review 9.  Erythrocyte disorders in the perinatal period.

Authors:  Laurie A Steiner; Patrick G Gallagher
Journal:  Semin Perinatol       Date:  2007-08       Impact factor: 3.300

Review 10.  Clinical and molecular pathophysiology of Shwachman-Diamond syndrome: an update.

Authors:  Kasiani C Myers; Stella M Davies; Akiko Shimamura
Journal:  Hematol Oncol Clin North Am       Date:  2012-11-03       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.